← NATIONAL HEALTH INVESTORS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $248.5m |
$278.7m
+12.14%
|
$294.6m
+5.72%
|
$318.1m
+7.97%
|
$332.8m
+4.63%
|
$298.7m
-10.24%
|
$35.8m
-88.02%
|
$319.8m
+793.49%
|
$335.2m
+4.80%
|
$375.6m
+12.07%
|
$401.5m
+6.88%
|
|
| Gains (Losses) on Sales of Investment Real Estate | $4.6m | $50k | $0 | $0 | $21.3m | $32.5m | $28.3m | $14.7m | $6.7m | $456k | — | |
| Interest Income (Expense), Net | — | — | — | — | — | — | $240.2m |
$268.7m
+11.87%
|
— | — | — | |
| General and Administrative Expense | $9.8m | $12.2m | $12.5m | $13.4m | $13.3m | $18.4m | $22.8m | $19.3m | $20.7m | $26.9m | $29.4m | |
| Labor and Related Expense | — | — | — | — | — | — | — | — | $17.2m | $27.5m | — | |
| Operating Expenses | $129.7m | $127.2m | $139.5m | $156.8m | $161.8m | $216.1m | $241.9m | $200.9m | $211.9m | $239.0m | $206.7m | |
| Other Operating Income | — | — | — | — | — | — | — | $202k | — | — | — | |
| Interest Expense | $43.1m | $46.3m | $49.1m | $56.3m | $52.9m | $50.8m | $44.9m | $58.2m | $59.9m | $57.4m | $54.8m | |
| Interest Income, Operating | $13.8m | $13.1m | $13.8m | $23.9m | $25.6m | $27.7m | $24.7m | — | — | — | — | |
| Investment Income, Net | $2.3m | $398k | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | ($1.2m) | $0 | $0 | — | ($3.1m) | ($1.5m) | $569k | $555k | $402k | $3.7m | — | |
| Other Income | $35.9m | $10.1m | $0 | $0 | $0 | $300k | $0 | $202k | $0 | $0 | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $118.8m | $151.5m | $155.1m | $161.3m | — | — | — | — | — | — | $146.7m | |
| Current Income Tax Expense (Benefit) | $42k | — | — | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $854k | $124k | $138k | — | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | $151.5m |
$159.4m
+5.16%
|
$154.3m
-3.16%
|
$160.5m
+3.97%
|
$185.1m
+15.37%
|
$111.8m
-39.61%
|
$66.4m
-40.61%
|
$135.7m
+104.29%
|
$138.0m
+1.72%
|
$142.2m
+3.04%
|
$147.9m
+4.02%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $151.5m |
$159.4m
+5.16%
|
$154.3m
-3.16%
|
$160.5m
+3.97%
|
$185.1m
+15.37%
|
$111.8m
-39.61%
|
$66.4m
-40.61%
|
$135.6m
+104.20%
|
$137.9m
+1.67%
|
$142.0m
+2.98%
|
$147.9m
+4.16%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.2m | $0 | $0 | ($7k) | $185k | $163k | ($902k) | ($1.3m) | ($1.3m) | ($1.4m) | $147.9m | |
| Earnings Per Share, Basic | $3.88 | $3.90 | $3.68 | $3.70 | $4.14 | $2.45 | $1.48 | $3.13 | $3.14 | $3.03 | $3.11 | |
| Earnings Per Share, Diluted | $3.87 | $3.87 | $3.67 | $3.67 | $4.14 | $2.44 | $1.48 | $3.13 | $3.13 | $3.02 | $3.10 | |
| Common Stock, Dividends, Per Share, Declared | $3.60 | $3.80 | $4.00 | $0.00 | $4.41 | $3.80 | $3.60 | $3.60 | $3.60 | $3.64 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 39.0m | 40.9m | 41.9m | 43.4m | 44.7m | 45.7m | 44.8m | 43.4m | 43.8m | 46.9m | 47.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | 39.2m | 41.2m | 42.1m | 43.7m | 44.7m | 45.7m | 44.8m | 43.4m | 44.1m | 47.1m | 47.7m | |
| Additional Financial Items | ||||||||||||
| Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal | — | — | — | — | — | — | — | $138k | $4.8m | $3.5m | — | |
| Lease Income | — | — | — | — | — | $271.0m | $217.7m | $249.2m | $257.0m | $271.6m | — | |
| Management Fee Expense | — | — | — | — | — | — | — | — | — | $4.0m | — |